Just to add to my previous comment, the article is dated yesterday however it's part of their 2022 Q3 issue (it gets published quarterly). This just adds to the confusion about when the interview took place. Very good find, Respert!
(3)
(0)
CytoDyn Inc (CYDY) Stock Research Links
My comments are just my opinions and should NOT be taken as investment advice.